Lack of interleukin-6 expression is not protective against focal central nervous system ischemia - PubMed (original) (raw)
Lack of interleukin-6 expression is not protective against focal central nervous system ischemia
W M Clark et al. Stroke. 2000 Jul.
Abstract
Background and purpose: Interleukin-6 (IL-6) appears to be involved in the inflammatory response associated with central nervous system (CNS) ischemia. Although IL-6 levels increase after stroke, it is not known whether IL-6 directly influences CNS ischemic injury. In this study, we used a focal reversible stroke model to investigate whether mice lacking IL-6 were protected against acute ischemic injury.
Methods: We bred IL-6-deficient C57 black mice (I-129 IL-6 KO back-crossed with C57), including homozygous knockouts (IL-6 -/-), heterozygous littermates (IL-6 +/-), and normal littermates (IL-6 +/+). The status of all animals was confirmed by DNA sampling and polymerase chain reaction analysis. Reversible middle cerebral artery occlusion was produced by advancing a silicone-coated 8-0 filament into the internal carotid artery for 2 hours (experiment 1) or 45 minutes (experiment 2). At 24 hours, animals were evaluated on a 28-point clinical scale, blood and cerebrospinal fluid were obtained, and the brains were evaluated for infarct volume and IL-6 mRNA levels.
Results: In experiment 1 (severe ischemia), no differences were seen in lesion size or neurological function between the groups: lesion volume was IL-6 -/- (n=15), 57+/-13 mm(3); IL-6 +/- (n=15), 58+/-23 mm(3); and IL-6 +/+ (n=15), 58+/-18 mm(3) (P=NS). ELISA testing confirmed very low to absent levels of IL-6 in the serum and cerebrospinal fluid of knockout animals. Brain mRNA levels of the other proinflammatory cytokines, including tumor necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonist, were 50% lower in IL-6-deficient ischemic animals than in normal animals. In experiment 2 (mild ischemia), no differences were seen in lesion size or neurological function between the groups: lesion volume was IL-6 -/- (n=10), 16+/-8 mm(3); IL-6 +/- (n=10), 14+/-4 mm(3); and IL-6 +/+ (n=10), 19+/-12 mm(3) (P=NS).
Conclusions: In this study, infarct size and neurological function at 24 hours were not different in animals deficient in IL-6 after transient CNS ischemia. This suggests that IL-6 does not have a direct influence on acute ischemic injury. Further study investigating the role of IL-6 on long-term recovery after stroke is in progress.
Similar articles
- Time course of IL-6 expression in experimental CNS ischemia.
Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein F. Clark WM, et al. Neurol Res. 1999 Apr;21(3):287-92. doi: 10.1080/01616412.1999.11740933. Neurol Res. 1999. PMID: 10319338 - Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia.
Zhu Y, Saito K, Murakami Y, Asano M, Iwakura Y, Seishima M. Zhu Y, et al. Neurosci Lett. 2006 Jan 30;393(2-3):122-6. doi: 10.1016/j.neulet.2005.08.072. Epub 2005 Dec 13. Neurosci Lett. 2006. PMID: 16356636 - Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats.
Wang X, Barone FC, Aiyar NV, Feuerstein GZ. Wang X, et al. Stroke. 1997 Jan;28(1):155-61; discussion 161-2. doi: 10.1161/01.str.28.1.155. Stroke. 1997. PMID: 8996505 - Clinical significance of acute phase reaction in stroke patients.
Dziedzic T. Dziedzic T. Front Biosci. 2008 Jan 1;13:2922-7. doi: 10.2741/2897. Front Biosci. 2008. PMID: 17981765 Review. - Targeting the central nervous system inflammatory response in ischemic stroke.
Becker KJ. Becker KJ. Curr Opin Neurol. 2001 Jun;14(3):349-53. doi: 10.1097/00019052-200106000-00014. Curr Opin Neurol. 2001. PMID: 11371759 Review.
Cited by
- Interleukin-6: A Constitutive Modulator of Glycoprotein 130, Neuroinflammatory and Cell Survival Signaling in Retina.
Echevarria FD, Rickman AE, Sappington RM. Echevarria FD, et al. J Clin Cell Immunol. 2016 Aug;7(4):439. doi: 10.4172/2155-9899.1000439. Epub 2016 Jul 22. J Clin Cell Immunol. 2016. PMID: 27747134 Free PMC article. - Downstream Toll-like receptor signaling mediates adaptor-specific cytokine expression following focal cerebral ischemia.
Famakin B, Mou Y, Spatz M, Lawal M, Hallenbeck J. Famakin B, et al. J Neuroinflammation. 2012 Jul 16;9:174. doi: 10.1186/1742-2094-9-174. J Neuroinflammation. 2012. PMID: 22799573 Free PMC article. - Inflammatory biomarkers of ischemic stroke.
Tirandi A, Sgura C, Carbone F, Montecucco F, Liberale L. Tirandi A, et al. Intern Emerg Med. 2023 Apr;18(3):723-732. doi: 10.1007/s11739-023-03201-2. Epub 2023 Feb 6. Intern Emerg Med. 2023. PMID: 36745280 Free PMC article. Review. - Role of exogenous putrescine in the status of energy, DNA damage, inflammation, and spermidine/spermine-n(1)- acetyltransferase in brain ischemia-reperfusion in rats.
Cetin N, Dasdelen D, Mogulkoc R, Menevse E, Baltaci AK. Cetin N, et al. Iran J Basic Med Sci. 2022 May;25(5):597-603. doi: 10.22038/IJBMS.2022.63733.14046. Iran J Basic Med Sci. 2022. PMID: 35911644 Free PMC article. - Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.
Kim JY, Kawabori M, Yenari MA. Kim JY, et al. Curr Med Chem. 2014;21(18):2076-97. doi: 10.2174/0929867321666131228205146. Curr Med Chem. 2014. PMID: 24372209 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous